Whalegun
Home

Biomarin Pharmaceutical BMRN spent $530K on lobbying in Q1 2026 · Miscellaneous Tariff Bills, Health Issues and 1 more issue

Trade details

Type
Lobbying report
Amount
$530,000
Quarter
Q1 2026
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
26/04/20

Up 35.9% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Biomarin Pharmaceutical's other lobbying reports